 | REGENXBIO Inc. | |||
| NMS : RGNX || Location: United States | ||||
$15.69-0.42 (-2.61%) |
0.57 M | 15.32 - 16.26 | ||
| Last Updated:America/New_York | Volume | Day range |
Total Call Open Interest - | Total Put Open Interest -
Today's Total Call volume - | Total Put volume -
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 3.946 M |
| March 15, 2024 | 4.150 M |
| Feb. 29, 2024 | 3.832 M |
| Feb. 15, 2024 | 4.174 M |
| Jan. 31, 2024 | 4.148 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.30 | -1.43 | -10.34% |
| 09/30/2023 | -1.55 | -1.41 | 8.92% |
| 06/30/2023 | -1.41 | -1.66 | -17.51% |
| 03/31/2023 | -1.57 | -1.53 | 2.39% |
| 12/31/2022 | -1.26 | -1.38 | -9.61% |
RGNX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 49.043M | Shares Float | 37.365M |
| Short Float | 3.946M | Market Cap | 769.48M |
| Institution ownership | 81.73% | Insider ownership | 7.177% |
| Earnings Date | 05/01/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -6.02 | Forward EPS | -2.19 |